Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 277

Results For "PLI"

2763 News Found

Jan Aushadi Kendras to achieve record sales of Rs. 600 Cr in FY 2020-21
News | January 15, 2021

Jan Aushadi Kendras to achieve record sales of Rs. 600 Cr in FY 2020-21

In FY 2020-2021 (upto 12th January 2021) Jan Aushadhi Kendras have completed sales of Rs. 484 crores at 7,064 Pradhan Mantri Bhartiya Jan Aushadhi Kendras

Commercial disinfectants equally as effective against new COVID strains: CBC
News | January 13, 2021

Commercial disinfectants equally as effective against new COVID strains: CBC

Viruses evolve into new strains when there is a change to their genetic composition.

LASA receives WHO nod for its Ratnagiri unit
Policy | January 13, 2021

LASA receives WHO nod for its Ratnagiri unit

Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.

Latest Stories

Strides acquires identified ANDAs from Nostrum Laboratories, USA

RPG Life Sciences posts Q4 FY25 net profit at Rs. 117.35 Cr

Zydus Lifesciences completes 25 years of listing on NSE

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging